References
- Pritchard J, McElwain T J., Graham-Pole J. High dose melphalan with autologous marrow for treatment of advanced neuroblastoma. Br J Cancer 1982; 45: 86–94
- Cornbleet M A., Corringham R ET, Prentice H G., Boesen E M., McElwain T J. Treatment of Ewing's sarcoma with high dose melphalan and autologous bone marrow transplantation. Cancer Treat Rep 1981; 65: 241–4
- McElwain T J., Hedley D W., Gordon M Y., Jarman M, Millar J L., Pritchard J. High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma. Exp Haematol 1979; 7: 360–71, [Suppl 5]
- McElwain T J., Hedley D W., Burton G, Clink H M., Gordon M Y., Jarman M J., Juttner C A., Millar J L., Milsted R AV, Prentice G, Smith I E., Spence D, Woods M. Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan. Br J Cancer 1979; 40: 72–80
- Kemshead J T., Walsh F, Pritchard J, Greaves M. Monoclonal antibody to ganglioside GQ discriminates between haemopoietic cells and infiltrating neuroblastoma cells in bone marrow. Int J Cancer 1981; 27: 447–52
- Millar J L., Phelps T A., Carter R L., McElwain T J. Cyclophosphamide pretreatment reduces the toxic effect of high dose melphalan an intestinal epithelium in sheep. Eur J Cancer 1978; 14: 1283–5
- Watson J G., Jameson B, Powles R L., McElwain T J., Lawson D N., Judson I, Morgenstern G R., Lumley H, Kay H EM. Co-trimoxazole versus non-absorbable antibiotics in acute leukaemia. Lancet 1982; II: 6–9
- Kingston J E., Malpas J S., Stiller C A., Pritchard J, McElwain T J. Autologous bone marrow transplantation contributes to haemopoietic recovery in children with solid tumours treated with high dose melphalan. Br J Haematol 1984; 58: 589–95
- Ninane J, Pritchard J, Malpas J S. Treatment of advanced neuroblastoma: Does adriamycin contribute. Arch Dis Child 1981; 56: 544–8
- Gasparini M, Bellani F F., Musumeci R, Bonadonna G. Response and survival of patients with metastatic neuroblastoma after combination chemotherapy with adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and vincristine (NSC-67574). Cancer Chemother Rep 1974; 58: 365–70
- Finklestein J Z., Klemperer M R., Evans A E., Bernstein I, Leikin S, McCreadie S, Grosfeld J, Hittle R, Weiner J, Sather J, Hammond D. Multiagent chemotherapy for children with metastatic neuroblastoma: a report from Children's Cancer Study Group. Med Pediatr Oncol 1979; 6(2)179–88